AB002 (E-WE Thrombin)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AB002 (E-WE Thrombin), covering 2022-03-15 to 2022-03-15. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy Study of AB002 (E-WE Thrombin) in End Stage Renal Disease Patients on Chronic Hemodialysis [Phase 2]